SCHEMBL363060

SCHEMBL363060

O=C(CC(c1ccccc1)c1ccccc1)c1cc(Cl)ncc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.42
HTT P42858 1/20 0.42
TACR1 P25103 3/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ASPH Q12797 1/20 0.36
KDM8 Q8N371 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ALDH1A1 P00352 2/20 0.35
EPHX2 P34913 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
P2RX7 Q99572 1/20 0.35
DCAF1 Q9Y4B6 1/20 0.35
ALPL P05186 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10290808 0.83 NPSR1 (0.39) NPSR1HTTTACR1PPARGPPARA
SCHEMBL364474 0.81 GPBAR1 (0.38) NPSR1HTTTACR1PPARGPPARA
SCHEMBL10240934 0.81 GPBAR1 (0.38) NPSR1HTTTACR1PPARGPPARA
SCHEMBL364475 0.81 GPBAR1 (0.38) NPSR1HTTTACR1PPARGPPARA
SCHEMBL1390264 0.81 GPBAR1 (0.42) KMT2AGAA
SCHEMBL362406 0.78 HTT (0.42) NPSR1HTTTACR1MEN1KMT2A
SCHEMBL6223874 0.74 KDM4E (0.40) KDM4EASPHKDM8ALDH1A1
SCHEMBL12656137 0.74 KDM4E (0.40) KDM4EASPHKDM8MAPTALDH1A1
SCHEMBL29813883 0.73 ASPH (0.63) KDM4EASPHKDM8ALDH1A1
SCHEMBL16702319 0.73 ASPH (0.63) KDM4EASPHKDM8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 NPSR1 319/4885HTT 1564/4885TACR1 219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.